As HIF1α‐mediated PDK1 overexpression can lead to metabolic reprogramming,24 the relative ROS levels in CCA cells treated with PDK1 inhibitors, Ar‐12 and BX‐795, were analyzed and found to also be significantly increased (Figure 3D). This evidence concerns the gene PDK1 and cholangiocarcinoma.